Ethoxycarbonyl Group

Ethoxycarbonyl Group

SCHEMBL27656404

CCOC=O.ClCc1ccco1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
POLB P06746 4/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
TSHR P16473 1/20 0.36
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
LMNA P02545 1/20 0.34
CHRM2 P08172 1/20 0.34
EPHX2 P34913 1/20 0.34
RIPK1 Q13546 1/20 0.34
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethoxycarbonyl Group SCHEMBL27766174 0.83 ALDH1A1 (0.40) ALDH1A1POLBHPGDHSD17B10TP53
Ethoxycarbonyl Group SCHEMBL27495906 0.83 ALDH1A1 (0.40) ALDH1A1POLBHPGDHSD17B10TP53
Acetaldehyde SCHEMBL27471636 0.82 ALDH1A1 (0.43) ALDH1A1POLBHPGDMAPTHTT
Ether SCHEMBL20527592 0.80 ALDH1A1 (0.42) ALDH1A1POLBHPGDHSD17B10TP53
SCHEMBL28542440 0.80 ALDH1A1 (0.41) ALDH1A1POLBHPGDTSHRCHRM2
Ethoxycarbonyl Group SCHEMBL28772964 0.79 ALDH1A1 (0.35) ALDH1A1POLBHPGDHSD17B10TP53
SCHEMBL281641 0.78
Furfural SCHEMBL28172662 0.76 ALDH1A1 (0.64) ALDH1A1POLBHPGDHSD17B10MAPT
Ethoxycarbonyl Group SCHEMBL27691649 0.76 ALDH1A1 (0.35) ALDH1A1POLBHPGDHSD17B10TP53
SCHEMBL27885653 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105153179-B 4 β furoyl amine podophyllotoxin derivatives and preparation method and application 中国人民武装警察部队后勤学院 2017-05-31 CN disclosed
CN-104230827-B 1-(aryl methyl) quinazoline-2,4 (1H, 3H)-diketone is as PARP inhibitor and application thereof 南京英派药业有限公司 2016-10-26 CN disclosed
CN-105153179-A 4 beta-furoylamide type podophyllotoxin derivative as well as preparation method and application thereof MEDICAL COLLEGE CAPF 2015-12-16 CN disclosed
CN-104230827-A 1-(aryl methyl) quinazoline-2,4(1H,3H) diketone used as PARP (Poly-ADP-Ribose Polymerase) inhibitor and application thereof NANJING IMPACT THERAPEUTICS INC 2014-12-24 CN disclosed
CN-103097361-B 1- (arylmethyl) quinazoline-2, 4(1H,3H) -diketone serving as PARP inhibitor and application thereof NANJING IMPACT THERAPEUTICS INC 2014-08-06 CN disclosed
CN-103889976-A Indazole compounds, compositions and methods of use HOFFMANN LA ROCHE 2014-06-25 CN disclosed
CN-103304572-A 3-cyanoquinoline compound as well as pharmaceutical composition and application thereof SHANGHAI PHARMACEUTICAL GROUP CO LTD 2013-09-18 CN disclosed
CN-103097361-A 1- (arylmethyl) quinazoline-2, 4(1H,3H) -diketone serving as PARP inhibitor and application thereof NANJING IMPACT THERAPEUTICS INC 2013-05-08 CN disclosed
CN-100496499-C Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein ARROW THERAPEUTICS LTD (GB) 2009-06-10 CN disclosed
CN-100447136-C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors WARNER LAMBERT CO (US) 2008-12-31 CN disclosed
CN-101233114-A New imidazole carboxamides, useful to treat e.g. pathologies associated with the insulin resistance syndrome, are fructose-1,6-biphosphatase inhibitors MERCK PATENT GMBH (DE) 2008-07-30 CN disclosed
CN-1929848-A Benzodiazepines for treating or preventing or preventing RSV infection ARROW THERAPEUTICS LTD (GB) 2007-03-14 CN disclosed
CN-1498212-A New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors ��������ʲ��������ι�˾ 2004-05-19 CN disclosed